uu.seUppsala University Publications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Neurophysiological Measures of Efficacy and Safety for Botulinum Toxin Injection in Facial and Bulbar Muscles: Special Considerations
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Medical Sciences, Dermatology and Venereology.
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Neuroscience, Clinical Neurophysiology.
2017 (English)In: Toxins, ISSN 2072-6651, E-ISSN 2072-6651, Vol. 9, no 11, 352Article in journal (Refereed) Published
Abstract [en]

Botulinum toxin (BoNT) injections into facial and bulbar muscles are widely and increasingly used as medical treatments for cervical and facial dystonia, facial hemispasm, correction of facial palsy, hyperhidrosis, as well as cosmetic treatment of glabellar lines associated with grief and anger. Although BoNT treatment is generally considered safe, the diffusion of the toxin to surrounding muscles may result in complications, including difficulties swallowing, in a dose-dependent manner. The sensitivity of clinical examination for detecting adverse events after BoNT treatment is limited. Few reports have highlighted the potential effects on other muscles in the facial area due to the spreading of the toxin. The possibilities of spreading and thus unknown pharmacological BoNT effects in non-targeted muscles emphasise the importance of correct administration of BoNT in terms of dose selection, injection points, and appropriate effect surveillance. In this review article, we will focus on novel objective measures of efficacy and safety regarding BoNT treatment of facial muscles and the reasons why this is important.

Place, publisher, year, edition, pages
2017. Vol. 9, no 11, 352
Keyword [en]
CMAP, botulinum toxin, diffusion, facial muscles, glabella
National Category
Pharmacology and Toxicology
Research subject
Clinical Neurophysiology
Identifiers
URN: urn:nbn:se:uu:diva-335289DOI: 10.3390/toxins9110352PubMedID: 29084148OAI: oai:DiVA.org:uu-335289DiVA: diva2:1162113
Available from: 2017-12-03 Created: 2017-12-03 Last updated: 2017-12-05Bibliographically approved

Open Access in DiVA

fulltext(791 kB)2 downloads
File information
File name FULLTEXT01.pdfFile size 791 kBChecksum SHA-512
256ee60860f95f0396a48e2718b860a0b8a405315884d471d6d13fe9029aa2fe97ab286825172dfa892a99c668cbb909ad9da6b9adfdbc21a34fca902af5fca4
Type fulltextMimetype application/pdf

Other links

Publisher's full textPubMed

Authority records BETA

Alimohammadi, MohammedRostedt Punga, Anna

Search in DiVA

By author/editor
Alimohammadi, MohammedRostedt Punga, Anna
By organisation
Dermatology and VenereologyClinical Neurophysiology
In the same journal
Toxins
Pharmacology and Toxicology

Search outside of DiVA

GoogleGoogle Scholar
Total: 2 downloads
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 11 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf